Bio Plus Co

Bio Plus Co Cash Flow per Share

The Operating Cash Flow per Share of Bio Plus Co (099430.KQ) as of Nov 20, 2026 is 239.49 KRW. In the previous year, Operating Cash Flow per Share was 395.90 KRW — a change of -39.51% (lower).

Cash Flow per Share

239.49KRW

YoY

-39.51%

Last updated:

Operating Cash Flow per Share of Bio Plus Co is 2025 239.49 KRW. Operating Cash Flow per Share of Bio Plus Co was 2024 395.90 KRW. It decreases by -39.51% lower compared to the previous year.

The Bio Plus Co Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
56.59 KRW
Jan 1, 2019
89.20 KRW
Jan 1, 2020
180.49 KRW
Jan 1, 2021
238.24 KRW
Jan 1, 2022
230.61 KRW
Jan 1, 2023
280.49 KRW
Jan 1, 2024
395.90 KRW
Jan 1, 2025
239.49 KRW
The Bio Plus Co Cash Flow per Share history
YEARCash Flow per ShareYoY
239.49KRW-39.51%
395.90KRW+41.15%
280.49KRW+21.63%
230.61KRW-3.20%
238.24KRW+31.99%
180.49KRW+102.34%
89.20KRW+57.63%
56.59KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio Plus Co Stock analysis

What does Bio Plus Co do? BioPlus Co., Ltd. generates revenue through the manufacturing and sale of dermal fillers, primarily hyaluronic acid fillers for temporary facial wrinkle improvement. The company also produces and sells anti-adhesion agents to prevent surgical adhesions, biomaterials for joint tissue repair, and other tissue restoration products. These products are supplied to medical professionals and healthcare facilities requiring cosmetic and surgical solutions. The firm targets the medical and cosmetic sectors, focusing on tissue restoration applications for both aesthetic and functional needs. The company's product portfolio includes biomaterials for tissue restoration, specifically designed for temporary facial wrinkle correction, anti-adhesion solutions for surgical sites, and joint tissue repair materials. These offerings cater to healthcare providers seeking advanced biomaterials for patient care. BioPlus Co., Ltd. serves the medical industry by providing specialized products that address both cosmetic enhancement and post-surgical recovery requirements. BioPlus Co., Ltd. operates within the biomaterials sector, focusing on dermal fillers and tissue repair solutions. Its products are utilized by medical practitioners for facial aesthetics and surgical applications. The company's revenue streams are derived from direct sales of these biomaterial products to healthcare institutions and professionals in the medical field. Bio Plus Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio Plus Co stock

Operating Cash Flow per Share of Bio Plus Co is 239.49 KRW in 2025.

Operating Cash Flow per Share of Bio Plus Co changed from 395.90 KRW to 239.49 KRW, representing a -39.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Bio Plus Co since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Bio Plus Co

All Key Metrics — Bio Plus Co